Cargando…
Between-course targeting of methotrexate exposure using pharmacokinetically guided dosage adjustments
PURPOSE: It is advantageous to individualize high-dose methotrexate (HDMTX) to maintain adequate exposure while minimizing toxicities. Previously, we accomplished this through within-course dose adjustments. METHODS: In this study, we evaluated a strategy to individualize HDMTX based on clearance of...
Autores principales: | Pauley, Jennifer L., Panetta, John C., Crews, Kristine R., Pei, Deqing, Cheng, Cheng, McCormick, John, Howard, Scott C., Sandlund, John T., Jeha, Sima, Ribeiro, Raul, Rubnitz, Jeffrey, Pui, Ching-Hon, Evans, William E., Relling, Mary V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3719000/ https://www.ncbi.nlm.nih.gov/pubmed/23760811 http://dx.doi.org/10.1007/s00280-013-2206-x |
Ejemplares similares
-
Erratum to: Between-course targeting of methotrexate exposure using pharmacokinetically guided dosage adjustments
por: Pauley, Jennifer L., et al.
Publicado: (2013) -
Comprehensive analysis of dose intensity of acute lymphoblastic leukemia chemotherapy
por: Karol, Seth E., et al.
Publicado: (2021) -
Modeling Mechanisms of In Vivo Variability in Methotrexate Accumulation and Folate Pathway Inhibition in Acute Lymphoblastic Leukemia Cells
por: Panetta, John C., et al.
Publicado: (2010) -
In Vivo Response to Methotrexate Forecasts Outcome of Acute Lymphoblastic Leukemia and Has a Distinct Gene Expression Profile
por: Sorich, Michael J, et al.
Publicado: (2008) -
Clinical Impact of Minimal Residual Disease in Children with Different Subtypes of Acute Lymphoblastic Leukemia Treated with Response-Adapted Therapy
por: Pui, Ching-Hon, et al.
Publicado: (2016)